Pharmaceutical Pricing and R&D as a Global Public Good
Year of publication: |
May 2023
|
---|---|
Authors: | Frech, Henry Edward ; Pauly, Mark V. ; Comanor, William S. ; Martinez, Joseph R. |
Institutions: | National Bureau of Economic Research (issuing body) |
Publisher: |
Cambridge, Mass : National Bureau of Economic Research |
Subject: | Arzneimittel | Pharmaceuticals | Arzneimittelmarkt | Pharmaceutical market | Pharmaindustrie | Pharmaceutical industry | Preismanagement | Pricing strategy | Marktmechanismus | Market mechanism | Preistheorie | Price theory | Vergleich | Comparison | Welt | World | USA | United States |
Extent: | 1 Online-Ressource illustrations (black and white) |
---|---|
Series: | NBER working paper series ; no. w31272 |
Type of publication: | Book / Working Paper |
Type of publication (narrower categories): | Arbeitspapier ; Working Paper ; Graue Literatur ; Non-commercial literature |
Language: | English |
Notes: | Hardcopy version available to institutional subscribers |
Other identifiers: | 10.3386/w31272 [DOI] |
Classification: | I1 - Health |
Source: | ECONIS - Online Catalogue of the ZBW |
-
The Effect of Price Caps on Pharmaceutical Advertising : Evidence from the 340b Drug Pricing Program
Hristakeva, Sylvia, (2024)
-
Biosimilar Bias : A Barrier to Addressing American Drug Costs
Ho, Cynthia M., (2021)
-
Pricing new pharmaceutical products
Reekie, William Duncan, (1977)
- More ...
-
Costs and benefits of branded drugs : insights from cost-effectiveness research
Frech, Henry Edward, (2022)
-
Selection and Causal Effects in Voluntary Programs : Bundled Payments in Medicare
Gupta, Atul, (2023)
-
The competitive effects of vertical agrreements : reply
Comanor, William S., (1987)
- More ...